Company: ALAR
Filing Date: 2025-03-20
Form Type: 20-F
Source: 0001213900-25-025287
Chunk: 27

Company: Alarum Technologies Ltd.
Filing Date: 2025-03-20
Form: 20-F
Item: Item 3
Chunk 27
---
 contingent fee basis. It is difficult to predict the outcome of patent enforcement
litigation at a trial level as it is often difficult for juries and trial judges to understand complex, patented technologies, and, as
a result, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Regardless
of whether we prevail in the trial court, appeals are expensive and time consuming, resulting in increased costs and delayed revenue,
and attorneys may be less likely to represent us in an appeal on a contingency basis especially if we are seeking to appeal an adverse
decision. Although we may diligently pursue enforcement litigation, we cannot predict the decisions made by juries and trial courts. In
connection with patent enforcement actions, it is possible that a defendant may file counterclaims against us, or a court may rule that
we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the
substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our
operating subsidiaries or award attorney’s fees and/or expenses to the counterclaiming defendant, which could be material, and
if we or our operating subsidiaries are required to pay such monetary sanctions, attorneys’ fees and/or expenses, such payment
could materially harm our operating results, our financial position and our ability to continue in business.

Risks
Related to the Ownership of Our ADSs or Ordinary Shares

We
cannot guarantee that we will continue to comply with Nasdaq requirement. If we fail to comply with Nasdaq requirements, our ADSs could
be delisted from Nasdaq, and as a result we and our shareholders could incur material adverse consequences, including a negative impact
on our liquidity, our shareholders’ ability to sell shares and our ability to raise capital.

We
cannot guarantee that we will continue to comply with Nasdaq requirements. For example, in 2022, we failed to comply with Nasdaq’s
requirement that the closing bid price of our ADSs exceed $1.00. We subsequently changed the ratio of our ADSs to our Ordinary Shares
and regained compliance with Nasdaq’s minimum bid requirement. If we fail to demonstrate compliance with the minimum bid requirement
or any other Nasdaq requirement and satisfy Nasdaq’s conditions for continued listing, our Ordinary Shares could be delisted. Delisting
from Nasdaq could have an adverse effect on our business and on the trading of our Ordinary Shares. If a delisting of our Ordinary